Axel Nielsen
No más puestos en curso
Origen de la red de primer grado Axel Nielsen.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland.
19
| Extinct | Pharmaceuticals: Generic | 19 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Axel Nielsen a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arsenal Medical, Inc.
Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
The International Centre for Missing & Exploited Children
The International Centre for Missing & Exploited Children Services to the Health IndustryHealth Services The International Centre for Missing & Exploited Children is an organization that focuses on finding missing children and protecting children from exploitation worldwide. The non-profit company is based in Alexandria, VA and the CEO of the company is Paul Shapiro. The company's work involves powering the search for missing children and implementing measures to safeguard children from harm. | Services to the Health Industry | Director/Board Member | |
SWMF Life Science Venture Fund LP
SWMF Life Science Venture Fund LP Investment ManagersFinance SWMF Life Science Venture Fund LP invests in life science and medical device companies located in Southwest Michigan. It provides financing for start-up and early stage capital requirements. | Investment Managers | Chairman | |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Biotechnology | Director/Board Member | |
TESARO INC | Pharmaceuticals: Major | Director/Board Member | |
Tetra Therapeutics Inc.
Tetra Therapeutics Inc. BiotechnologyHealth Technology Tetra Therapeutics engages in the development of therapeutic products for neurological disorders. The firm offers BPN14770 PDE4D Inhibitor and PDE4B Inhibitor products. The company was founded by Mark E. Gurney in 2011 and is headquartered in Grand Rapids, MI. | Biotechnology | Chief Executive Officer | |
GSK PLC | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
University of Uppsala | College/University | Undergraduate Degree Graduate Degree | |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
Chroma Therapeutics Ltd.
Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Centers for Medicare & Medicaid Services (US)
Centers for Medicare & Medicaid Services (US) General GovernmentGovernment Centers for Medicare & Medicaid Services provides health care services. It offers medical and healthcare services for the people who are above 65 years. The organization also runs State Children's Health Insurance Program which helps states to cover children. Centers for Medicare & Medicaid Services was founded in 1977 and is located in Baltimore, MD | General Government | Corporate Officer/Principal | |
Mass General Brigham, Inc.
Mass General Brigham, Inc. Medical/Nursing ServicesHealth Services Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member | |
Glaxo Group Ltd.
Glaxo Group Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1935, Glaxo Group Ltd. is a subsidiary of GSK Plc. The company is based in Middlesex, UK. At GSK, we unite science, technology and talent to get ahead of disease together. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Linköping
University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Doctorate Degree | |
University of Iceland | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
US Department of Health & Human Services (DC) | General Government | Corporate Officer/Principal | |
RAND Health | Director/Board Member | ||
Archimedes Pharma UK Ltd.
Archimedes Pharma UK Ltd. Medical/Nursing ServicesHealth Services Archimedes Pharma UK Ltd. involves in marketing niche pharmaceutical products. The company is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
S*BIO Pte Ltd.
S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Pharmaceuticals: Major | Director/Board Member | |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman | |
Essex Woodlands Health Ventures UK Ltd. | Investment Managers | Corporate Officer/Principal | |
MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
American College of Rheumatology
American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services The American College of Rheumatology is an organization for physicians and health professionals. The non-profit company is based in Atlanta, GA. The company was founded by Göran Albert Torstensson Ando. | Miscellaneous Commercial Services | Founder | |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | Miscellaneous Commercial Services | Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Jazz Pharmaceuticals UK Ltd.
Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Fjord Holding LLC
Fjord Holding LLC Medical/Nursing ServicesHealth Services NextCODE Health LLC provides clinical diagnosis services. It is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges. The company was founded in 2013 by Jeffrey Gulcher and Hannes Thor Smarason and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal Sales & Marketing | |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Biotechnology | Chairman | |
The Grolier Club of New York | Corporate Officer/Principal | ||
NANEXA AB | Medical Specialties | Chairman Director/Board Member | |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member | |
Book Club of California | Corporate Officer/Principal | ||
Codex Foundation | Director/Board Member | ||
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director/Board Member | |
Astra Research Centre AB | Chairman Chief Tech/Sci/R&D Officer |
Estadísticas
Internacional
Estados Unidos | 24 |
Reino Unido | 9 |
Suecia | 7 |
Dinamarca | 4 |
Francia | 3 |
Sectorial
Health Technology | 29 |
Health Services | 5 |
Consumer Services | 5 |
Commercial Services | 4 |
Finance | 4 |
Operativa
Director/Board Member | 140 |
Corporate Officer/Principal | 57 |
Chairman | 36 |
Independent Dir/Board Member | 26 |
Undergraduate Degree | 16 |
Las relaciones más conectadas
Insiders | |
---|---|
Terry McGuire | 51 |
Göran Albert Ando | 44 |
Birgit Stattin Norinder | 29 |
Earl Collier | 24 |
Helga Zharov | 15 |
Jakob Sigurðsson | 14 |
Dan Hartman | 14 |
Peter Goodfellow | 13 |
Daniel C. Siu | 12 |
Lance Thibault | 11 |
Charles McDermott | 11 |
Linda B. Buck | 11 |
James R. Beery | 11 |
J. Neal Armstrong | 10 |
Richard A. Leach | 7 |
- Bolsa de valores
- Insiders
- Axel Nielsen
- Conexiones Empresas